Flair José Carrilho Selected Research

Flair José Carrilho Research Topics

Disease

13	Non-alcoholic Fatty Liver Disease 10/2022 - 10/2003
10	Infections 05/2021 - 08/2002
9	Fibrosis (Cirrhosis) 01/2022 - 10/2003
6	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 08/2002
6	Alcoholic Fatty Liver 10/2023 - 11/2006
6	Chronic Hepatitis C 01/2022 - 01/2002
6	Inflammation (Inflammations) 10/2018 - 03/2007
5	Liver Diseases (Liver Disease) 01/2021 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 01/2004
5	Chronic Hepatitis B 05/2020 - 04/2004
4	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 10/2017
3	End Stage Liver Disease 04/2022 - 09/2003
3	Hemorrhage 01/2022 - 12/2015
3	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2016
3	Yellow Fever 11/2019 - 01/2019
3	Hepatitis C 10/2017 - 01/2013
3	Lactose Intolerance (Intolerance, Lactose) 08/2016 - 05/2008
3	Insulin Resistance 08/2016 - 01/2008
2	Esophageal and Gastric Varices (Esophageal Varices) 01/2022 - 12/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 07/2014
2	COVID-19 01/2021 - 01/2020
2	Thrombocytopenia (Thrombopenia) 12/2020 - 07/2014
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 08/2020 - 09/2003
2	Abdominal Pain (Pain, Abdominal) 05/2020 - 04/2012
2	Crohn Disease (Crohn's Disease) 01/2020 - 12/2015
2	Chronic Renal Insufficiency 01/2020 - 01/2019
2	Acute Liver Failure (Fulminant Hepatic Failure) 11/2019 - 01/2019
2	Viremia 11/2019 - 01/2002
2	Pancreatitis 01/2019 - 10/2016
2	Chronic Pancreatitis 10/2016 - 10/2014
2	Portal Hypertension 12/2015 - 12/2009
2	Hepatitis B 12/2015 - 02/2010
2	Schistosomiasis (Bilharziasis) 01/2015 - 12/2009
2	Peptic Ulcer (Peptic Ulcers) 01/2007 - 12/2005
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2022
1	Siderosis 07/2022
1	Iron Overload 07/2022
1	Hepatic Encephalopathy 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Fatigue 05/2020
1	Nasopharyngitis 05/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 05/2020
1	Headache (Headaches) 05/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Hepatopulmonary Syndrome 01/2020

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
6	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 08/2002
5	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2009
5	EnzymesIBA 01/2022 - 11/2007
5	amsonic acid (DAS)IBA 05/2021 - 12/2015
5	Transaminases (Aminotransferases)IBA 01/2019 - 03/2007
4	InterferonsIBA 01/2022 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 10/2019 - 02/2010
4	UreaseIBA 11/2017 - 12/2005
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2022 - 07/2014
3	BilirubinIBA 04/2022 - 03/2017
3	LipidsIBA 01/2022 - 01/2014
3	Ribavirin (Virazole)FDA LinkGeneric 05/2021 - 01/2002
3	LactaseIBA 08/2016 - 05/2008
3	Insulin (Novolin)FDA Link 08/2016 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 01/2008
3	Choline (Choline Chloride)IBA 03/2007 - 10/2003
2	Serum AlbuminIBA 01/2022 - 10/2003
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2010
2	RNA (Ribonucleic Acid)IBA 05/2021 - 01/2002
2	ImmunosorbentsIBA 05/2021 - 01/2015
2	Immunoglobulin M (IgM)IBA 05/2021 - 01/2015
2	Immunoglobulin G (IgG)IBA 05/2021 - 01/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 10/2017
2	SofosbuvirIBA 11/2019 - 11/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2018 - 01/2016
2	Hepatitis B e AntigensIBA 06/2014 - 09/2009
2	InterleukinsIBA 01/2013 - 01/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2010 - 04/2004
2	microsomal triglyceride transfer proteinIBA 02/2010 - 12/2007
2	Glutathione (Reduced Glutathione)IBA 02/2010 - 03/2007
2	Methionine (L-Methionine)FDA Link 03/2007 - 11/2006
2	AntigensIBA 12/2005 - 09/2003
1	Phospholipases (Phospholipase)IBA 10/2022
1	HepcidinsIBA 07/2022
1	ApoferritinsIBA 07/2022
1	Ferritins (Ferritin)IBA 07/2022
1	CreatinineIBA 01/2022
1	CholesterolIBA 01/2022
1	Uncoupling Protein 3IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	CollagenIBA 01/2021
1	Collagen Type IV (Type IV Collagen)IBA 01/2021
1	von Willebrand FactorIBA 12/2020
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 08/2020
1	Sorafenib (BAY 43-9006)FDA Link 05/2020
1	nasIBA 05/2020

Therapy/Procedure

11	Therapeutics 10/2023 - 01/2002
10	Liver Transplantation 01/2022 - 07/2014
1	Duration of Therapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Length of Stay 01/2022
1	Ligation 12/2020
1	Bridge Therapy 05/2020